Drugs that contain Leuprolide Mesylate
1. Camcevi Kit patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10646572 | ACCORD | Pharmaceutical compositions with enhanced stability |
Jan, 2027
(3 years from now) | |
| US9744207 | ACCORD | Pharmaceutical compositions with enhanced stability |
Jan, 2027
(3 years from now) | |
| US9572857 | ACCORD | Pharmaceutical compositions with enhanced stability |
Jan, 2027
(3 years from now) | |
| US11717555 | ACCORD | Pharmaceutical compositions having a selected release duration |
Jan, 2039
(15 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product (NP) | May 25, 2024 |
Market Authorisation Date: 25 May, 2021
Treatment: NA
Dosage: EMULSION;SUBCUTANEOUS
More Information on Dosage
CAMCEVI KIT family patents
